The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation

The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation

书目详细资料
Main Authors:	Grozinsky-Glasberg, S, Rubinfeld, H, Cohen, O, Greif, F, Kammer, A, Grossman, AB, Shimon, I
格式:	Conference item
出版:	2011

相似书籍

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
由: Morris E Feldman, et al.
出版: (2009-02-01)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
由: Euphemia Y Leung, et al.
出版: (2015-01-01)

Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.
由: Quan Wang, et al.
出版: (2013-01-01)

Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
由: Liu, Qingsong, et al.
出版: (2015)

Smurf1 silencing restores PTEN expression that ameliorates progression of human glioblastoma and sensitizes tumor cells to mTORC1/C2 inhibitor Torin1
由: Qin Xia, et al.
出版: (2021-12-01)

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
由: Heng Du, et al.
出版: (2023-11-01)

Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
由: Jose A. Sandoval, et al.
出版: (2020-11-01)

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
由: Grozinsky-Glasberg, S, et al.
出版: (2008)

The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
由: Grozinsky-Glasberg, S, et al.
出版: (2009)

Regulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2
由: Paul A. Dutchak, et al.
出版: (2015-07-01)

Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
由: Dongjun Lee, et al.
出版: (2014-11-01)

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
由: Grozinsky-Glasberg, S, et al.
出版: (2010)

Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors
由: Althaf Shaik, et al.
出版: (2018-04-01)

RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma
由: Zhaoming Lu, et al.
出版: (2020-06-01)

A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.
由: Hao Zhang, et al.
出版: (2013-01-01)

mTORC1 and mTORC2 Levels in Patients With Psoriasis
由: İlayda Esna Gülsunay, et al.
出版: (2024-10-01)

A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
由: Sarah J. Mahoney, et al.
出版: (2018-02-01)

mTORC inhibitors as broad-spectrum therapeutics for age-related diseases
由: Walters, H, et al.
出版: (2018)

TORSEL, a 4EBP1-based mTORC1 live-cell sensor, reveals nutrient-sensing targeting by histone deacetylase inhibitors
由: Canrong Li, et al.
出版: (2024-06-01)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
由: Haiyang Tang, PhD, et al.
出版: (2018-12-01)

An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma
由: Odai Darawshi, et al.
出版: (2022-11-01)

Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
由: Aruna D Balgi, et al.
出版: (2009-09-01)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
由: Mathis Wehming, et al.
出版: (2023-02-01)

mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
由: Khalid W Kalim, et al.
出版: (2017-01-01)

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
由: Edward Wolin, et al.
出版: (2019-01-01)

Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling
由: David M. Walter, et al.
出版: (2023-03-01)

Author Correction: Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor
由: Sameer Ullah Khan, et al.
出版: (2022-05-01)

Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
由: Polina Kosillo, et al.
出版: (2022-07-01)

mTORC1 and mTORC2 differentially promote natural killer cell development
由: Chao Yang, et al.
出版: (2018-05-01)

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
由: Jin Young Yang, et al.
出版: (2019-06-01)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
由: Xiaolei Ding, et al.
出版: (2016-10-01)

Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
由: Micol Silic-Benussi, et al.
出版: (2023-03-01)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
由: Druce, MR, et al.
出版: (2009)

Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
由: Milad Ghomlaghi, et al.
出版: (2021-09-01)

Regulation of Autophagy through TORC1 and mTORC1
由: Takeshi Noda
出版: (2017-07-01)

The localization of mTORC1 signaling
由: Peterson, Timothy Richard, Ph.D. Massachusetts Institute of Technology
出版: (2010)

Regulation of nuclear mTORC1
由: Xin Zhou, et al.
出版: (2021-05-01)

In Silico Design of Novel Piperazine-Based mTORC1 Inhibitors Through DFT, QSAR and ADME Investigations
由: El Mehdi Karim, et al.
出版: (2024-10-01)

NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
由: Nutan Sharma, et al.
出版: (2024-10-01)

The autophagy inhibitor NSC185058 suppresses mTORC1-mediated protein anabolism in cultured skeletal muscle
由: Patrick J. Ryan, et al.
出版: (2024-04-01)